These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6852845)

  • 1. Unit dose analysis of digoxin in tablet formulations marketed in India.
    Bansinath M; Shukla VK; Chopra KS; Bidwai PS; Mathur VS
    Indian Heart J; 1983; 35(1):54-9. PubMed ID: 6852845
    [No Abstract]   [Full Text] [Related]  

  • 2. The application of conductivity measurements to evaluate commercial digoxin tablet formulations.
    Rubinstein MH; Wells JI
    Pharm Acta Helv; 1977; 52(5):112-5. PubMed ID: 928471
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated fluorometric procedure for unit dose analysis of digitoxin and digoxin in tablet formulations.
    Cullen LF; Packmsn DL; Papariello GJ
    J Pharm Sci; 1970 May; 59(5):697-9. PubMed ID: 5446430
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro characterisation of digoxin tablets marketed in India.
    Bansinath M; Shukla VK; Chopra KS; Mathur VS
    Indian J Med Res; 1983 Mar; 77():395-400. PubMed ID: 6874025
    [No Abstract]   [Full Text] [Related]  

  • 5. [Content uniformity for digoxin tablet].
    Tokunaga H; Kimura T; Kawamura J
    Eisei Shikenjo Hokoku; 1974; 49(92):66-70. PubMed ID: 4477502
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physiologic availability of phenylbutazone tablets marketed in India.
    Manek SP; Tipnis HP; Kulkarni RD
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):163-7. PubMed ID: 7263103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the bioequivalence of 4- and 8-mg benidipine tablets in healthy volunteers after a single oral dose.
    Kang WK; Yun HY; Kwon KI
    J Clin Pharm Ther; 2005 Feb; 30(1):85-90. PubMed ID: 15659008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors affecting dissolution of digoxin from tablets.
    Hasegawa S; Sonobe T; Kawata H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Jul; 26(7):2098-104. PubMed ID: 688533
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Aug; 41(8):1230-7. PubMed ID: 7447117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated assay of single tablets of digoxin.
    Myrick JW
    J Pharm Sci; 1969 Aug; 58(8):1018-21. PubMed ID: 5344515
    [No Abstract]   [Full Text] [Related]  

  • 13. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of quality control parameters and interchangeability of multisourced metformin HCl tablets marketed in Nigeria.
    Osadebe PO; Akabogu IC
    Boll Chim Farm; 2004 May; 143(4):170-3. PubMed ID: 15255340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control practices for calcium, cholesterol, digoxin, and hemoglobin: a College of American Pathologists Q-probes study in 505 hospital laboratories.
    Steindel SJ; Tetrault G
    Arch Pathol Lab Med; 1998 May; 122(5):401-8. PubMed ID: 9593339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic and toxic plasma concentrations of digoxin in the cat.
    Erichsen DF; Harris SG; Upson DW
    Am J Vet Res; 1980 Dec; 41(12):2049-58. PubMed ID: 7212438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
    Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J
    J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.